The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for anaphylaxis; this is the first needle-free alternative to injectable products like EpiPen The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for anaphylaxis; this is the first needle-free alternative to injectable products like EpiPen Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
U.S. FDA approves first nasal spray to treat dangerous allergic reactions
